Razzaghi et al identified risk behaviors in injecting drug users. These can help identify patients at risk for HIV, HCV or other infections. The authors are from Tehran University of Medical Sciences and Yale University.
Most injection drug users are male.
Parameters:
(1) lifestyle stability
(2) HIV risk
Lifestyle |
High Stability |
Intermediate |
Low Stability |
housing |
at home with family |
at home with family |
irregular, homeless |
economic resources |
good |
fair |
poor |
social support |
good |
fair, often other addicts |
poor, with many problems |
emotional support |
good |
fair |
none |
injection site |
at home |
public place or safe house |
public place |
criminal behavior |
none |
some |
regular |
personal hygiene |
good |
fair |
poor |
The authors found that the majority of injecting drug users had a stable lifestyle, indicating that the social impact of injection use may be underestimated if only obvious drug users are considered.
HIV Risk |
Low Risk |
Intermediate |
High Risk |
handling of syringe and needle |
boils or heats |
licks point, rinses with water then flushes with boiling water |
licks point, rinses with water, wipes tip on cloth or paper, or none |
injection alone |
|
|
often |
reuse of syringes |
none or infrequent |
common |
almost all of the time |
repeated reinjections of blood (blood play) |
none or infrequent |
common |
common |
syringe sharing |
none or infrequent |
occasional to frequent |
almost all of the time |
sharing of other equipment |
none to frequent |
common |
almost all of the time |
access to pharmacy sold syringes |
available |
limited access |
very limited access |
risk awareness |
aware and tries to reduce risk |
aware but continues risky behaviors |
unaware or disregards |
The optimum response for an injecting drug user depends on where the person is on the spectrum. Interventions may include:
(1) availability of sterile syringes
(2) safer injection facilities
(3) counseling
(4) social support
(5) access to methadone maintenance programs
(6) training
Purpose: To evaluate an injection drug user for lifestyle stability and HIV risk.
Specialty: Infectious Diseases
Objective: physical and lifestyle, compliance/adherence
ICD-10: F11, F19, Z50.3,